Evidence map›Paper›PMID 24765613›Full record

ReviewFrontiers in oncology2014

High-Risk HPVs and Human Carcinomas in the Syrian Population.

Ala-Eddin Al Moustafa, Lina Ghabreau, Nizar Akil, Samer Rastam, Amal Alachkar, Amber Yasmeen

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Human papillomavirus (HPV) types 16 and 18 in liquid-based cervical cytology samples.Virchows Archiv : an international journal of pathology · 2015
    Article
  11. Article
  12. Human Papilloma Viruses and Breast Cancer.Frontiers in oncology · 2015
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ala-Eddin Al MoustafaABS Research and Development , Montreal, QC , Canada ; Oncology Department, McGill University , Montreal, QC , Canada ; Department of Mechanical Engineering, Concordia University , Montreal, QC , Canada ; Syrian Research Cancer Centre of the Syrian Society against Cancer , Aleppo , Syria.
Lina GhabreauSyrian Research Cancer Centre of the Syrian Society against Cancer , Aleppo , Syria ; Faculty of Medicine, Pathology Department, Aleppo University , Aleppo , Syria.
Nizar AkilSyrian Research Cancer Centre of the Syrian Society against Cancer , Aleppo , Syria ; Faculty of Medicine, Pathology Department, Aleppo University , Aleppo , Syria.
Samer RastamSyrian Research Cancer Centre of the Syrian Society against Cancer , Aleppo , Syria ; Faculty of Medicine, Pathology Department, Aleppo University , Aleppo , Syria.
Amal AlachkarFaculty of Pharmacy, Pharmacology Department, Aleppo University , Aleppo , Syria.
Amber YasmeenOncology Department, McGill University , Montreal, QC , Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) infection is the most common sexually transmitted infection; persistent infection with high-risk types of HPV present a major risk factor for the initiation and progression of a variety of human carcinomas including cervical, colorectal, head, and neck (HN) as well as breast carcinomas. A huge number of studies investigated and reported the incidence of high-risk HPVs in these cancers worldwide particularly in the developed countries; therefore, two HPV prophylactic vaccines against the two most frequent high-risk HPV types (16 and 18) have been developed and used worldwide. However, there are very limited studies about the prevalence of HPVs in the developing countries especially in Africa and some states of the Middle East. In this mini review, we outline the presence of high-risk HPVs in human cervical, colorectal, HN as well as breast cancers in the Syrian population, which was recently explored for the first time by a Canadian/Syrian group.

Indexed as

HPVshuman carcinomasSyrian population

Identifiers

PMID24765613
PMCPMC3980109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.